Market Cap 449.50B
Revenue (ttm) 88.82B
Net Income (ttm) 14.07B
EPS (ttm) N/A
PE Ratio 18.01
Forward PE 17.21
Profit Margin 15.84%
Debt to Equity Ratio 0.50
Volume 6,959,200
Avg Vol 8,326,976
Day's Range N/A - N/A
Shares Out 2.41B
Stochastic %K 39%
Beta 0.38
Analysts Strong Sell
Price Target $202.35

Company Profile

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood...

Industry: Drug Manufacturers - General
Sector: Healthcare
Phone: 732 524 0400
Website: www.jnj.com
Address:
One Johnson & Johnson Plaza, New Brunswick, United States
LiquidThetaOptions
LiquidThetaOptions Nov. 9 at 3:32 AM
💎 LiquidTheta® Live Actionable Trade Asset: $JNJ Contracts: $JNJ December 18, 2026 $190 Calls Scale in: $13.10- $16.01 Scale out: $50.93-$87.31 Profit Potential : 239% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
StratSoldier
StratSoldier Nov. 8 at 11:24 PM
$JNJ inside week #trading #theStrat
0 · Reply
biolover
biolover Nov. 8 at 5:32 PM
$JNJ $VKTX JNJ probably needs medical guy at the helm. It is slowly getting to be similar case to $MRK ( although with Merck Dean LI CMO who makes decision on BD ). But the Joaquin Duato guy lacks global view on human health issues. The Dominance in multiple myeloma may end as every company has assets now. And $ABBV is eating JNJ lunch in immunology. While revenues still good .. what is in pipeline not enough to continue leadership. $LLY ABBV and others will leap over JNJ Particularly when ABBV gets heavy in obesity as I expect.
0 · Reply
wwmeinc
wwmeinc Nov. 8 at 4:57 PM
$VKTX $JNJ ....Ask anything these days and something pops up that has a 50/50 chance of proceeding....also having lots of billions on the balance sheet allows for some real speculation...all based on the premise that $VKTX is next up on the B/O ladder...these LLM(Google) are helpful though....Looking forward to the next moves on the chess board that is this weight-loss/cardio sector...glta "Johnson & Johnson's primary weakness in the obesity sector is the lack of a blockbuster weight-loss drug in its portfolio, leaving it unable to directly compete with market leaders like Eli Lilly and Novo Nordisk. This has several negative consequences: " "Accelerated Development: JNJ's extensive resources and global commercial infrastructure could significantly speed up the development, clinical trials (e.g., cardiovascular outcomes trials), and commercialization of Viking's drugs, potentially bringing them to market faster than Viking could independently..."
0 · Reply
Suite510
Suite510 Nov. 8 at 1:56 PM
$KVUE $JNJ $SPX $SPY I should be at Goldman trading 😂 Texas Attorney General Ken Paxton asked a state judge on Thursday to block Kenvue (KVUE.N) from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from Tylenol
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 8 at 12:32 PM
Enter: $JNJ Calls Strike Price: $190 Expiry Date: NOV 28 2025 Buy in Price: $1.89 - $1.90 Sell Price: $4.14 Profit : +118% (Turn every $1 into $2.18) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
DidYouReadThis
DidYouReadThis Nov. 7 at 7:19 PM
$JNJ friends, can someone please share a bookmarked calculator for estimating the value of a small pharma company pre vs post FDA approval? Thank you!
0 · Reply
Twills08
Twills08 Nov. 7 at 6:59 PM
$ITRM Sticking to my original prediction of a $5 BO. The longer this has to gain traction the higher the BO multiple. $6-10 is definitely in play with interval developments. I expect EC to show increased national traction from insurance co’s and uptrending script numbers, likely modest as it gains momentum. BO can occur at any time. The picture at large is highly suggestive of it. The easiest play on the national stage for Fishman is to hand it off to $INVA or $PFE (who humorously is going to lose out on another play bc of lowballing). $MRK and $JNJ are possible suitors. For these folks, this is spare change in their underwear drawer.
3 · Reply
Baddb
Baddb Nov. 7 at 6:34 PM
$JNJ will 185.60 hold or 😬😂
0 · Reply
SBAlpha
SBAlpha Nov. 7 at 5:58 PM
0 · Reply
Latest News on JNJ
Johnson & Johnson: Dividends Don't Lie

Nov 7, 2025, 5:40 AM EST - 1 day ago

Johnson & Johnson: Dividends Don't Lie


Cramer's Mad Dash: Johnson & Johnson

Nov 6, 2025, 9:54 AM EST - 2 days ago

Cramer's Mad Dash: Johnson & Johnson


Best Dividend Aristocrats For November 2025

Nov 1, 2025, 10:25 AM EDT - 7 days ago

Best Dividend Aristocrats For November 2025

ABBV ABT ADM ADP AMCR AOS ATO


Best Dividend Kings: October 2025

Oct 29, 2025, 5:11 AM EDT - 10 days ago

Best Dividend Kings: October 2025

ABBV ABM ABT ADM ADP AWR BDX


J&J Stock Can Fall

Oct 28, 2025, 9:25 AM EDT - 11 days ago

J&J Stock Can Fall


Johnson & Johnson Stock To $134?

Oct 22, 2025, 2:00 PM EDT - 17 days ago

Johnson & Johnson Stock To $134?


Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript

Oct 14, 2025, 12:36 PM EDT - 25 days ago

Johnson & Johnson (JNJ) Q3 2025 Earnings Call Transcript


J&J to spin off orthopedics business, raises full-year forecast

Oct 14, 2025, 6:26 AM EDT - 25 days ago

J&J to spin off orthopedics business, raises full-year forecast


Johnson & Johnson in Talks to Buy Protagonist Therapeutics

Oct 10, 2025, 11:13 AM EDT - 4 weeks ago

Johnson & Johnson in Talks to Buy Protagonist Therapeutics

PTGX


LiquidThetaOptions
LiquidThetaOptions Nov. 9 at 3:32 AM
💎 LiquidTheta® Live Actionable Trade Asset: $JNJ Contracts: $JNJ December 18, 2026 $190 Calls Scale in: $13.10- $16.01 Scale out: $50.93-$87.31 Profit Potential : 239% ROI Blended Join 💎 Here: https://liquidtheta.com
0 · Reply
StratSoldier
StratSoldier Nov. 8 at 11:24 PM
$JNJ inside week #trading #theStrat
0 · Reply
biolover
biolover Nov. 8 at 5:32 PM
$JNJ $VKTX JNJ probably needs medical guy at the helm. It is slowly getting to be similar case to $MRK ( although with Merck Dean LI CMO who makes decision on BD ). But the Joaquin Duato guy lacks global view on human health issues. The Dominance in multiple myeloma may end as every company has assets now. And $ABBV is eating JNJ lunch in immunology. While revenues still good .. what is in pipeline not enough to continue leadership. $LLY ABBV and others will leap over JNJ Particularly when ABBV gets heavy in obesity as I expect.
0 · Reply
wwmeinc
wwmeinc Nov. 8 at 4:57 PM
$VKTX $JNJ ....Ask anything these days and something pops up that has a 50/50 chance of proceeding....also having lots of billions on the balance sheet allows for some real speculation...all based on the premise that $VKTX is next up on the B/O ladder...these LLM(Google) are helpful though....Looking forward to the next moves on the chess board that is this weight-loss/cardio sector...glta "Johnson & Johnson's primary weakness in the obesity sector is the lack of a blockbuster weight-loss drug in its portfolio, leaving it unable to directly compete with market leaders like Eli Lilly and Novo Nordisk. This has several negative consequences: " "Accelerated Development: JNJ's extensive resources and global commercial infrastructure could significantly speed up the development, clinical trials (e.g., cardiovascular outcomes trials), and commercialization of Viking's drugs, potentially bringing them to market faster than Viking could independently..."
0 · Reply
Suite510
Suite510 Nov. 8 at 1:56 PM
$KVUE $JNJ $SPX $SPY I should be at Goldman trading 😂 Texas Attorney General Ken Paxton asked a state judge on Thursday to block Kenvue (KVUE.N) from paying a nearly $400 million shareholder dividend this month, after suing the drugmaker for allegedly concealing risks to children from Tylenol
1 · Reply
MoneyGroupLLC
MoneyGroupLLC Nov. 8 at 12:32 PM
Enter: $JNJ Calls Strike Price: $190 Expiry Date: NOV 28 2025 Buy in Price: $1.89 - $1.90 Sell Price: $4.14 Profit : +118% (Turn every $1 into $2.18) Want Profitable Real-Time Options Alerts? 👉 https://moneygroup.us
0 · Reply
DidYouReadThis
DidYouReadThis Nov. 7 at 7:19 PM
$JNJ friends, can someone please share a bookmarked calculator for estimating the value of a small pharma company pre vs post FDA approval? Thank you!
0 · Reply
Twills08
Twills08 Nov. 7 at 6:59 PM
$ITRM Sticking to my original prediction of a $5 BO. The longer this has to gain traction the higher the BO multiple. $6-10 is definitely in play with interval developments. I expect EC to show increased national traction from insurance co’s and uptrending script numbers, likely modest as it gains momentum. BO can occur at any time. The picture at large is highly suggestive of it. The easiest play on the national stage for Fishman is to hand it off to $INVA or $PFE (who humorously is going to lose out on another play bc of lowballing). $MRK and $JNJ are possible suitors. For these folks, this is spare change in their underwear drawer.
3 · Reply
Baddb
Baddb Nov. 7 at 6:34 PM
$JNJ will 185.60 hold or 😬😂
0 · Reply
SBAlpha
SBAlpha Nov. 7 at 5:58 PM
0 · Reply
Baddb
Baddb Nov. 7 at 5:50 PM
$JNJ bought few calls for funsies why not 😂✌️
0 · Reply
AlphaByAI
AlphaByAI Nov. 7 at 5:41 PM
$MDT $ABT $BSX $SYK $JNJ A deep dive into five large-cap US Medical Devices stocks. https://newsletter.ai-wk.com/p/us-medical-devices-watchlist
0 · Reply
Baddb
Baddb Nov. 7 at 5:39 PM
$JNJ $ORGO dividends have decreased once talc lawsuits play out they may get bought out 😂
0 · Reply
Baddb
Baddb Nov. 7 at 5:29 PM
$JNJ weekly’s worthless now waiting for next decent move to counter 😂
0 · Reply
bilocelhi
bilocelhi Nov. 7 at 5:22 PM
$ORGO surprised no major bio such as $JNJ has bought this out
0 · Reply
Baddb
Baddb Nov. 7 at 5:17 PM
$JNJ back red 😂
0 · Reply
Baddb
Baddb Nov. 7 at 5:12 PM
$JNJ spy pumping this dumping it’s like clockwork 😂
0 · Reply
Baddb
Baddb Nov. 7 at 5:03 PM
$JNJ I’d imagine that was too
0 · Reply
Baddb
Baddb Nov. 7 at 4:58 PM
$JNJ I don’t think we get passed 188 but if we do 189 will get rejected and we fall back to 187
0 · Reply
Baddb
Baddb Nov. 7 at 4:56 PM
$JNJ you’d think this would run a few dollars as down as spy is 🤷‍♂️😂
0 · Reply
Baddb
Baddb Nov. 7 at 4:55 PM
$JNJ guess someone did that’s nuts at these prices 😂✌️
0 · Reply
Baddb
Baddb Nov. 7 at 4:54 PM
$JNJ algos tried so hard to pump nobody wants it here 😂
0 · Reply